Carbamazepine Tablet, Extended Release
Product Images NDC 70518-3911

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-3911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Carbamazepine 400 mg extended-release oral tablets packaging label showing a quantity of 100 tablets per box. The label features the brand RemedyRepack and includes a warning that tablets must be swallowed whole and not crushed or chewed. The manufacturer is Cadista Pharma, Inc., with repackaging by RemedyRepack Inc., Indiana, PA.*

FDA Label Image

Mm2 (Carbamazepine 400mg 70518 3911 01)

Label for Carbamazepine extended-release tablet, 400 mg, unit dose packaging of 1 tablet. The label includes administration warnings, handling instructions, and mentions manufacturing by Cadista Pharma. The labeler is RemedyRepack Inc., Indiana, PA. Barcodes and a QR code are present for scanning.*

FDA Label Image

Image Description (Carbamazepine Structure)

Chemical structure diagram of carbamazepine, showing its molecular framework with a dibenzazepine ring system and amide functional group as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.